Inhibition of tissue factor-factor VIIa by nafamostat mesilate; a reply to the rebuttal

Antiproliferative constituents in Umbelliferae plants II. Screening for polyacetylenes in some Umbelliferae plants, and isolation of panaxynol and falcarindiol from the root of Heracleum moellendorffii.

Biological & pharmaceutical bulletin·1998

[A case report: right ventricular outflow tract (RVOT) reconstruction using homograft for RVOT restenosis after Jatene's procedure of transposition of the great arteries (TGA)].

Kyobu geka. The Japanese journal of thoracic surgery·1998

Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and alpha-cyclodextrin sulfate.

Clinical chemistry·1998

Right ventricular obstruction by tricuspid pouch in simple ventricular septal defect.

The Annals of thoracic surgery·1998

[A prospective study on the timing of discontinuation of aspirin before coronary artery bypass grafting].

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai·1997

Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.

Thrombosis and haemostasis·1997

The calf clot of the lungs: Detection, overdiagnosis, and structured surveillance in isolated subsegmental pulmonary embolism.

Thrombosis research·2026

Perioperative haemostatic management and bleeding outcomes in congenital factor VII deficiency: a retrospective cohort study.

Thrombosis research·2026

Fibrinogen activity and postpartum hemorrhage risk in women with congenital fibrinogen disorders: A multicenter real-world study.

Thrombosis research·2026

The Factor VII mutation F7 c.760T>C (FVIIp.Cys254Arg) is causative for Factor VII deficiency by impairing secretion.

Thrombosis research·2026

A human-cell recombinant prethrombin-2 platform producing thrombin with enhanced fibrinogen processing for in vitro applications.

Thrombosis research·2026

Anticoagulation quality in antiphospholipid syndrome according to INR testing strategy.

Thrombosis research·2026

Five decades of gene therapy innovation and regulation in the US and EU: a historical analysis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Hemoporfin Research Progress - Part II: Clinical applications of Hemoporfin PDT for the treatment of Port-Wine Stain (PWS) birthmarks.

Photodiagnosis and photodynamic therapy·2026

Bioorthogonal chemistries for theranostics and radioconjugates.

Advanced drug delivery reviews·2026

Metformin-loaded multi-enzymatic metal-organic framework nanozyme mediates metabolic reprogramming via multiple energy blockades to boost tumor immunotherapy.

Acta biomaterialia·2026

Lipid nanoparticle-mediated co-delivery of human RB1 mRNA and triptolide for localized genetic therapy of retinoblastoma.

Journal of controlled release : official journal of the Controlled Release Society·2026

Mid-Term Clinical Outcomes of Tendyne Transcatheter Mitral Valve Replacement: A Prospective Cohort of 100 Patients with Follow-up to 4 Years.

The Journal of thoracic and cardiovascular surgery·2026

Related Experiment Videos

Inhibition of tissue factor-factor VIIa by nafamostat mesilate; a reply to the rebuttal

Related Concept Videos

Antiproliferative constituents in Umbelliferae plants II. Screening for polyacetylenes in some Umbelliferae plants, and isolation of panaxynol and falcarindiol from the root of Heracleum moellendorffii.

[A case report: right ventricular outflow tract (RVOT) reconstruction using homograft for RVOT restenosis after Jatene's procedure of transposition of the great arteries (TGA)].

Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and alpha-cyclodextrin sulfate.

Right ventricular obstruction by tricuspid pouch in simple ventricular septal defect.

[A prospective study on the timing of discontinuation of aspirin before coronary artery bypass grafting].

Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.

The calf clot of the lungs: Detection, overdiagnosis, and structured surveillance in isolated subsegmental pulmonary embolism.

Perioperative haemostatic management and bleeding outcomes in congenital factor VII deficiency: a retrospective cohort study.

Fibrinogen activity and postpartum hemorrhage risk in women with congenital fibrinogen disorders: A multicenter real-world study.

The Factor VII mutation F7 c.760T>C (FVIIp.Cys254Arg) is causative for Factor VII deficiency by impairing secretion.

A human-cell recombinant prethrombin-2 platform producing thrombin with enhanced fibrinogen processing for in vitro applications.

Anticoagulation quality in antiphospholipid syndrome according to INR testing strategy.

Five decades of gene therapy innovation and regulation in the US and EU: a historical analysis.

Hemoporfin Research Progress - Part II: Clinical applications of Hemoporfin PDT for the treatment of Port-Wine Stain (PWS) birthmarks.

Bioorthogonal chemistries for theranostics and radioconjugates.

Metformin-loaded multi-enzymatic metal-organic framework nanozyme mediates metabolic reprogramming via multiple energy blockades to boost tumor immunotherapy.

Lipid nanoparticle-mediated co-delivery of human RB1 mRNA and triptolide for localized genetic therapy of retinoblastoma.

Mid-Term Clinical Outcomes of Tendyne Transcatheter Mitral Valve Replacement: A Prospective Cohort of 100 Patients with Follow-up to 4 Years.

Related Experiment Videos

Inhibition of tissue factor-factor VIIa by nafamostat mesilate; a reply to the rebuttal

Related Concept Videos

Related Articles